246 related articles for article (PubMed ID: 8510410)
1. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
Filer RS; Song JC; Char DH; Kaleta-Michaels S
Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic profile of uveal melanoma.
Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
6. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
8. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
10. Novel cell lines derived by long-term culture of primary uveal melanomas.
Nareyeck G; Zeschnigk M; Bornfeld N; Anastassiou G
Ophthalmologica; 2009; 223(3):196-201. PubMed ID: 19212147
[TBL] [Abstract][Full Text] [Related]
11. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
14. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
17. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
19. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
20. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]